Rani Therapeutics Holdings Inc RANI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
5.22UNCH (UNCH)
Volume
709,339
Close
5.22quote price arrow down-0.24 (-4.40%)
Volume
114,459
52 week range
1.82 - 8.75
Loading...
  • Open5.52
  • Day High5.74
  • Day Low5.01
  • Prev Close5.46
  • 52 Week High8.75
  • 52 Week High Date04/17/24
  • 52 Week Low1.82
  • 52 Week Low Date11/02/23

Key Stats

  • Market Cap263.194M
  • Shares Out50.42M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.34
  • YTD % Change57.23

KEY STATS

  • Open5.52
  • Day High5.74
  • Day Low5.01
  • Prev Close5.46
  • 52 Week High8.75
  • 52 Week High Date04/17/24
  • 52 Week Low1.82
  • 52 Week Low Date11/02/23
  • Market Cap263.194M
  • Shares Out50.42M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.34
  • YTD % Change57.23

RATIOS/PROFITABILITY

  • EPS (TTM)-1.29
  • P/E (TTM)-4.05
  • Fwd P/E (NTM)-5.59
  • EBITDA (TTM)-62.735M
  • ROE (TTM)-173.56%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-3,126.87%
  • Debt To Equity (MRQ)397.93%

EVENTS

  • Earnings Date08/22/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Rani Therapeutics Holdings Inc

 

Profile

MORE
Rani Therapeutics Holdings, Inc. is a clinical-stage biotherapeutics company. The Company is focused on advancing technologies to enable the administration of biologics and drugs orally, to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. It has developed a drug-agnostic oral delivery platform, the RaniPill capsule, which is designed to deliver a variety of drug substances, including antibodies, proteins, peptides, and...
Mir Imran
Executive Chairman of the Board
Talat Imran
Chief Executive Officer, Director
Svai Sanford
Chief Financial Officer
Eric Groen
General Counsel
Address
2051 Ringwood Avenue
San Jose, CA
95131
United States

Top Peers

SYMBOLLASTCHG%CHG
RAPT
RAPT Therapeutics Inc
4.04-0.10-2.42%
CRDF
Cardiff Oncology Inc
3.63-0.11-2.94%
ACHV
Achieve Life Sciences Inc
5.00-0.07-1.38%
RGLS
Regulus Therapeutics Inc
2.00UNCHUNCH
PRAX
Praxis Precision Medicines Inc
45.39+0.18+0.40%